1
|
Valter R, Paillaud E, Boudou-Rouquette P, Oubaya N, Arégui A, Lorisson E, Brain E, Rochette de Lempdes G, Histe A, Laurent M, Canouï-Poitrine F, Caillet P, Broussier A, Martinez-Tapia C. Comparison of the prognostic value of eight nutrition-related tools in older patients with cancer: A prospective study. J Nutr Health Aging 2024; 28:100188. [PMID: 38350302 DOI: 10.1016/j.jnha.2024.100188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 02/01/2024] [Accepted: 02/02/2024] [Indexed: 02/15/2024]
Abstract
OBJECTIVES The primary objective of the present study was to evaluate and compare the ability of eight nutrition-related tools to predict 1-year mortality in older patients with cancer. DESIGN, SETTING AND PARTICIPANTS We studied older patients with cancer from the ELCAPA cohort and who had been referred for a geriatric assessment at one of 14 participating geriatric oncology clinics in the greater Paris area of France between 2007 and 2018. MEASUREMENTS The studied nutrition-related tools/markers were the body mass index (BMI), weight loss (WL) in the previous 6 months, the Mini Nutritional Assessment, the Geriatric Nutritional Risk Index (GNRI), the Prognostic Nutritional Index, the Glasgow Prognostic Score (GPS), the modified GPS, and the C-reactive protein/albumin ratio. RESULTS A total of 1361 patients (median age: 81; males: 51%; metastatic cancer: 49%) were included in the analysis. Most of the tools showed a progressively increase in the mortality risk as the nutrition-related risk category worsened (overall p-values <0.02 for all) after adjustment for age, outpatient status, functional status, severe comorbidities, cognition, mood, cancer treatment strategy, tumour site, and tumour metastasis. All the models were discriminant, with a C-index ranging from 0.748 (for the BMI) to 0.762 (for the GPS). The concordance probability estimate ranged from 0.764 (WL) to 0.773 (GNRI and GPS)). CONCLUSION After adjustment for relevant prognostic factors, all eight nutrition-related tools/markers were independently associated with 1-year mortality in older patients with cancer. Depending on the time or context of the GA, physicians do not always have the time or means to perform and assess all the tools/markers compared here. However, even when some information is missing, each nutritional tool/marker has prognostic value and can be used in the evaluation.
Collapse
Affiliation(s)
- Rémi Valter
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France
| | - Elena Paillaud
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; AP-HP, Paris Cancer Institute CARPEM, hôpital Européen Georges Pompidou, département de gériatrie, F-75015 Paris, France
| | | | - Nadia Oubaya
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; AP-HP, Hopital Henri-Mondor, Service de Santé Publique, F-94010 Creteil, France
| | - Amélie Arégui
- APHP, Hôpital St Louis, UCOG Paris Nord, F-75010 Paris, France
| | | | - Etienne Brain
- Institut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France
| | | | - Axelle Histe
- AP-HP, Hopital Henri-Mondor, Unité de Recherche Clinique, F-94010 Creteil, France
| | - Marie Laurent
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; AP-HP, Hopital Henri-Mondor, Department of Internal Medicine and Geriatrics, F-94010 Creteil, France
| | - Florence Canouï-Poitrine
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; AP-HP, Hopital Henri-Mondor, Service de Santé Publique, F-94010 Creteil, France
| | - Philippe Caillet
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; AP-HP, Paris Cancer Institute CARPEM, hôpital Européen Georges Pompidou, département de gériatrie, F-75015 Paris, France
| | - Amaury Broussier
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; AP-HP, Hopitaux Henri-Mondor/Emile Roux, Department of Geriatrics, F-94456 Limeil-Brevannes, France
| | | |
Collapse
|
2
|
Lamarque C, Segaux L, Bachellier P, Buchard B, Chermak F, Conti F, Decaens T, Dharancy S, Di Martino V, Dumortier J, Francoz-Caudron C, Gugenheim J, Hardwigsen J, Muscari F, Radenne S, Salamé E, Uguen T, Ursic-Bedoya J, Antoine C, Deshayes A, Jacquelinet C, Natella PA, Leroy V, Cherqui D, Oubaya N, Duvoux C. Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study. J Hepatol 2024:S0168-8278(24)00202-2. [PMID: 38521171 DOI: 10.1016/j.jhep.2024.03.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 02/09/2024] [Accepted: 03/09/2024] [Indexed: 03/25/2024]
Abstract
INTRODUCTION To maximize utility and prevent premature liver transplantation (LT), a delayed LT strategy (DS) was adopted in France in 2015 in patients listed for any single HCC treated with resection or thermal-ablation during waiting phase, postponing LT until recurrence. The purpose of this study was to evaluate DS to make sure that it did not hamper pre and post-LT outcomes in DS patients. PATIENTS AND METHODS Patients listed for HCC in France between 2015 and 2018 were studied. After data extraction from the national LT database, 2,025 patients were identified and classified according to 6 groups: single tumor entering DS, single tumor not entering DS, multiple tumors, no curative treatment, untreatable HCC or T1 tumors. 18-months Kaplan-Meier estimates of drop-out for death, too sick to be transplanted or tumor progression before LT, 5-year post-LT HCC recurrence and post LT-survival rates were compared. RESULTS Median waiting-time in DS group was 910 days. Pre-LT drop-out probability was significantly lower in DS compare to other groups (13% vs 19%, p=0.0043) and significantly higher in the T1 group (25.4%, p=0.05). Post-LT HCC-recurrence rate in multiples nodules group was significantly higher (19.6%, p= 0.019) and post-LT 5-year survival did not differ among groups with 74% in DS group (p=0.22). CONCLUSION The DELTA HCC study shows that DS does not negatively impact neither pre- nor post-LT patients 'outcomes, and has the potential to redistribute organs to patients in more urgent need of LT. It can reasonably be proposed and pursued. The unexpected high risk of drop out in T1 patients seems related to the MELD-based driving rules underserving this subgroup, calling for revision of allocation rules. IMPACTS AND IMPLICATIONS To maximize utility and prevent premature liver transplantation (LT), a delayed LT strategy (DS) was adopted in France in 2015. It consists in postponing LT until recurrence in patients listed for any single HCC curatively treated by surgical resection or thermal ablation. The DELTA HCC study was conducted to evaluate this nationwide strategy. It shows in a non-US, European LT program that DS:- does not negatively impact pre- nor post-LT patients 'outcome,- concerns up to 20% of LT candidates-has therefore the potential to redistribute organs to patients in more urgent need of LT. Such a delayed strategy can reasonably be pursued and extended to other LT programs. Of note, an unexpected high risk of drop out in T1 patients, seemingly related to MELD-based offering rules which underserve these patients, calls for further scrutinization and revision of allocation rules in this subgroup.
Collapse
|
3
|
Celante H, Oubaya N, Fourati S, Beaune S, Khellaf M, Casalino E, Ricard JD, Vieillard-Baron A, Heming N, Dessap AM, de Montmollin E, Benghanem S, Epaillard N, Layese R, de Prost N. Prognosis of hospitalized adult patients with respiratory syncytial virus infection: a multicenter retrospective cohort study. Clin Microbiol Infect 2023:S1198-743X(23)00117-9. [PMID: 36914069 DOI: 10.1016/j.cmi.2023.03.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 02/26/2023] [Accepted: 03/05/2023] [Indexed: 03/15/2023]
Abstract
OBJECTIVES Respiratory syncytial virus (RSV) is a common agent of viral respiratory infections with significant morbidity and mortality in adults. The objective of this study is to determine risk factors for mortality, invasive mechanical ventilation and to describe the characteristics of patients who received ribavirin. METHODS Retrospective multicenter observational cohort study conducted in Great Paris area hospitals, including patients hospitalized between January 1, 2015 and December 31, 2019 for documented RSV infection. Data were extracted from the AP-HP Health Data Warehouse. The primary endpoint was in-hospital mortality. RESULTS 1168 patients were hospitalized for RSV infection, including 288 (24.6%) patients who required ICU admission. The median [interquartile range] age of patients was 75 [63-85] years, 54% (n=631/1168) of them were women. In-hospital mortality was 6.6% (n=77/1168) in the whole cohort and 12.8% (n=37/288) in ICU patients. Factors associated with hospital mortality were age>85 years (adjusted odds ratio (aOR)=6.29 95% confidence interval [2.47-15.98]), acute respiratory failure (aOR=2.83 [1.19-6.72]), non-invasive (aOR=12.60 [1.41-112.36]) and invasive mechanical ventilation support (aOR=30.13 [3.17-286.27]) and neutropenia (aOR=13.19 [3.27-53.27]). Factors associated with invasive mechanical ventilation were chronic heart (aOR=1.98 [1.20-3.26]) or respiratory failure (aOR=2.83 [1.67-4.80]), and co-infection (aOR=2.62 [1.60-4.30]). Patients who were treated with ribavirin were significantly younger than others (62 [55-69] vs 75 [63-86] years; p<0.001), more frequently males (n=34/48 (70.8%) vs n=503/1120 (44.9%); p=0.001), and almost exclusively immunocompromised (n=46/48 (95.8%) vs n=299/1120 (26.7%); p<0.001). CONCLUSIONS The mortality rate of patients hospitalized with RSV infections was 6.6%. Twenty-five percent of patients required ICU admission.
Collapse
Affiliation(s)
- Héloïse Celante
- Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor- Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France; Groupe de Recherche Clinique CARMAS, Université Paris Est-Créteil, Créteil, France
| | - Nadia Oubaya
- Univ Paris Est Créteil, INSERM, IMRB, F-94010 Créteil, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Department of Public Health, F-94010 Créteil, France
| | - Slim Fourati
- Department of Virology, Hôpitaux Universitaires Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France; INSERM U955, Team « Viruses, Hepatology, Cancer », Créteil, France
| | - Sébastien Beaune
- Service D'Accueil des Urgences, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne Billancourt, France
| | - Mehdi Khellaf
- Université Paris-Est Créteil Val de Marne (UPEC), Créteil, France; Service D'Accueil des Urgences, Hôpitaux Universitaires Henri Mondor- Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France
| | - Enrique Casalino
- Service D'Accueil des Urgences, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Jean-Damien Ricard
- Université Paris Cité, AP-HP, Hôpital Louis Mourier, DMU ESPRIT, Service de Médecine Intensive Réanimation, Colombes, France
| | - Antoine Vieillard-Baron
- Service de Médecine Intensive Réanimation, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne-Billancourt, France; CESP, UMR 1018, Université Paris-Saclay
| | - Nicholas Heming
- Service de Réanimation Polyvalente, Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris (AP-HP), Clamart, France
| | - Armand Mekontso Dessap
- Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor- Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France; Groupe de Recherche Clinique CARMAS, Université Paris Est-Créteil, Créteil, France; Univ Paris Est Créteil, INSERM, IMRB, F-94010 Créteil, France
| | - Etienne de Montmollin
- Service Médecine Intensive Réanimation, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Sara Benghanem
- Service de Médecine Intensive Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Nicolas Epaillard
- Service de Médecine Intensive Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Richard Layese
- Univ Paris Est Créteil, INSERM, IMRB, F-94010 Créteil, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Clinical Research Unit, F-94010 Créteil, France
| | - Nicolas de Prost
- Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor- Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France; Groupe de Recherche Clinique CARMAS, Université Paris Est-Créteil, Créteil, France.
| | | |
Collapse
|
4
|
Bastuji-Garin S, Brouard L, Bourgeon-Ghittori I, Zebachi S, Boutin E, Hemery F, Fourreau F, Oubaya N, De Roux Q, Mongardon N, Fourati S, Decousser JW. The Relative Contributions of Occupational and Community Risk Factors for COVID-19 among Hospital Workers: The HOP-COVID Cohort Study. J Clin Med 2023; 12:jcm12031208. [PMID: 36769854 PMCID: PMC9917902 DOI: 10.3390/jcm12031208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Revised: 01/27/2023] [Accepted: 01/31/2023] [Indexed: 02/05/2023] Open
Abstract
The relative contributions of occupational and community sources of COVID-19 among health-care workers (HCWs) are still subject to debate. In a cohort study at a 2814-bed tertiary medical center (five hospitals) in the Paris area of France, we assessed the proportion of hospital-acquired cases among staff and identified risk factors. Between May 2020 and June 2021, HCWs were invited to complete a questionnaire on their COVID-19 risk factors. RT-PCR and serology test results were retrieved from the virology department. Mixed-effects logistic regression was used to account for clustering by hospital. The prevalence of COVID-19 was 15.6% (n = 213/1369 respondents) overall, 29.7% in the geriatric hospitals, and 56.8% of the infections were hospital-acquired. On multivariable analyses adjusted for COVID-19 incidence and contact in the community, a significantly higher risk was identified for staff providing patient care (especially nursing assistants), staff from radiology/functional assessment units and stretcher services, and staff working on wards with COVID-19 clusters among patients or HCWs. The likelihood of infection was greater in geriatric wards than in intensive care units. The presence of significant occupational risk factors after adjustment for community exposure is suggestive of a high in-hospital risk and emphasizes the need for stronger preventive measures-especially in geriatric settings. Clinicaltrials.gov NCT04386759.
Collapse
Affiliation(s)
- Sylvie Bastuji-Garin
- IMRB, INSERM, University Paris Est Creteil, 94010 Créteil, France
- Department of Public Health, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
- Correspondence: (S.B.-G.); (J.-W.D.)
| | - Ludivine Brouard
- Clinical Research Unit (URC Mondor), Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Irma Bourgeon-Ghittori
- IMRB, INSERM, University Paris Est Creteil, 94010 Créteil, France
- CARMAS, University Paris Est Creteil, 94010 Créteil, France
- DMU SAPHIRE, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Sonia Zebachi
- Clinical Research Unit (URC Mondor), Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Emmanuelle Boutin
- IMRB, INSERM, University Paris Est Creteil, 94010 Créteil, France
- Clinical Research Unit (URC Mondor), Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Francois Hemery
- Département d’Information Médicale, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Frédéric Fourreau
- Equipe Opérationnelle d’Hygiène, Département Prévention, Diagnostic, Traitement des Infections, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Nadia Oubaya
- IMRB, INSERM, University Paris Est Creteil, 94010 Créteil, France
- Department of Public Health, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Quentin De Roux
- Service D’Anesthésie-Réanimation Chirurgicale, DMU CARE, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Nicolas Mongardon
- IMRB, INSERM, University Paris Est Creteil, 94010 Créteil, France
- Service D’Anesthésie-Réanimation Chirurgicale, DMU CARE, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
- IMRB, EnvA, 94700 Maisons-Alfort, France
| | - Slim Fourati
- Département de Virologie, Bactériologie, Parasitologie-Mycologie, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
| | - Jean-Winoc Decousser
- Equipe Opérationnelle d’Hygiène, Département Prévention, Diagnostic, Traitement des Infections, Hôpitaux Universitaires Henri-Mondor AP-HP, 94010 Créteil, France
- DYNAMYC, University Paris Est Creteil, 94010 Créteil, France
- DYNAMYC, EnvA, 94700 Maisons-Alfort, France
- Correspondence: (S.B.-G.); (J.-W.D.)
| |
Collapse
|
5
|
Oubaya N, Pombet T, Delestrain C, Remus N, Douvry B, Grenet D, Corvol H, Thouvenin G, Prulière-Escabasse V, Mounir H, Argoud D, Fretigne C, Costes L, Mackiewicz MP, Jung C, Ahamada L, Lanone S, Maitre B, Bégot AC, Epaud R. Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN). Front Public Health 2022; 10:978627. [PMID: 36452951 PMCID: PMC9703073 DOI: 10.3389/fpubh.2022.978627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2022] [Accepted: 10/19/2022] [Indexed: 11/16/2022] Open
Abstract
Background Most of the studies on cystic fibrosis (CF) focused on SARS-CoV-2 prevalence and suggested a low incidence of infection in this population. We aimed to assess the impact of the pandemic and related lockdown measures implemented in May 2020 in response to the first wave of SARS-CoV-2 infection on healthcare access, health, and behavior in CF patients. Methods A national questionnaire opened online from May 15th, 2020 to June 11th, 2020 was completed by 751 CF-patients, aged 14 years and over. It comprised questions about access to healthcare, anxiety and depression, smoking, alcohol, drug and psychotropic drug consumption, adherence to CF treatment, and constraints. A semi-structured comprehensive interview was performed no later than 1 month after the end of the lockdown in 16 CF-patients. Results The mean age of the population was 28.0 [interquartile range (IQR) 20.0-37.0] years old. More than 75% of in-person consultations scheduled during the lockdown were canceled. Alternatively, 27% were postponed, and telehealth consultations were proposed and accepted in almost 40% of cases. More than 75% of the scheduled physiotherapy sessions were canceled and replaced mainly by self-drainage. Annual follow-up clinic visits were consistently postponed whereas required hospitalizations at CF centers for exacerbation were maintained in most cases. While 43.2% CF-patients had signs of anxiety, 51.0% presented symptoms of depression, both associated with increased use of psychotic medications and inversely correlated to COVID-19 prevalence. Among the lower and lower middle classes, very little medical information was obtained or requested by the patient, participation to sports or other activities was low, while excessive home confinement and isolation were more frequent. In contrast, in the upper middle and upper classes, individuals solicitated help to their CF centre, had more physical activities, and maintained contact with friends or families. Conclusion The first lockdown in France had only minimal impact on the management care of CF-patients but was associated with increased symptoms of anxiety and depression, together with behavioral changes that varied with social class. Trial registration NCT04463628.
Collapse
Affiliation(s)
- Nadia Oubaya
- Department of Public Health, AP-HP, Hôpitaux Henri-Mondor, Créteil, France,University Paris Est Créteil, INSERM, IMRB, Créteil, France
| | - Thibaud Pombet
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France,Faculté d'Éducation et de Formation, Institut Catholique de Paris (ICP), Paris, France
| | - Celine Delestrain
- University Paris Est Créteil, INSERM, IMRB, Créteil, France,Centre Hospitalier Intercommunal de Créteil, Service de Pédiatrie Générale, Créteil, France,Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France,Fédérations Hospitalo-Universitaires (FHU) Role of SENEscence in Chronic Diseases (SENEC), Créteil, France
| | - Natascha Remus
- Centre Hospitalier Intercommunal de Créteil, Service de Pédiatrie Générale, Créteil, France,Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France
| | - Benoit Douvry
- Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France,Centre Hospitalier Intercommunal de Créteil, Service de Pneumologie, Créteil, France
| | - Dominique Grenet
- Service de Pneumologie, CRCM-Centre de Transplantation Pulmonaire, Hôpital Foch, Suresnes, France
| | - Harriet Corvol
- Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Pediatric Pulmonary Department, Paris, France,Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche Saint Antoine, Paris, France
| | - Guillaume Thouvenin
- Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Pediatric Pulmonary Department, Paris, France
| | - Virginie Prulière-Escabasse
- University Paris Est Créteil, INSERM, IMRB, Créteil, France,Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France,Centre Hospitalier Intercommunal de Créteil, Service d'ORL, Créteil, France
| | - Hakima Mounir
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France
| | - Dominique Argoud
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France
| | - Cédric Fretigne
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France
| | - Laurence Costes
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France
| | - Marie-Pierre Mackiewicz
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France
| | - Camille Jung
- Clinical Research Centre, Intercommunal Hospital of Créteil, Créteil, France
| | - Laitissia Ahamada
- Clinical Research Centre, Intercommunal Hospital of Créteil, Créteil, France
| | - Sophie Lanone
- University Paris Est Créteil, INSERM, IMRB, Créteil, France,Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France,Fédérations Hospitalo-Universitaires (FHU) Role of SENEscence in Chronic Diseases (SENEC), Créteil, France
| | - Bernard Maitre
- University Paris Est Créteil, INSERM, IMRB, Créteil, France,Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France,Fédérations Hospitalo-Universitaires (FHU) Role of SENEscence in Chronic Diseases (SENEC), Créteil, France,Centre Hospitalier Intercommunal de Créteil, Service de Pneumologie, Créteil, France
| | - Anne-Cécile Bégot
- Laboratoire Interdisciplinaire de Recherche sur les Transformations des Pratiques Éducatives et des Pratiques Sociales (LIRTES)-EA7313, Université Paris-Est Créteil Val-de-Marne, Créteil, France
| | - Ralph Epaud
- University Paris Est Créteil, INSERM, IMRB, Créteil, France,Centre Hospitalier Intercommunal de Créteil, Service de Pédiatrie Générale, Créteil, France,Centre des Maladies Respiratoires Rares (RESPIRARE), CRCM, Créteil, France,Fédérations Hospitalo-Universitaires (FHU) Role of SENEscence in Chronic Diseases (SENEC), Créteil, France,*Correspondence: Ralph Epaud
| |
Collapse
|
6
|
Segaux L, Oubaya N, Leissing-Desprez C, Cleret De Langavant L, Broussier A, Naga H, Fromentin I, David JP, Bastuji-Garin S. More than a third of middle-aged adults (50-65) have understated executive dysfunction. Aging Ment Health 2022; 27:708-713. [PMID: 35243938 DOI: 10.1080/13607863.2022.2046696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
OBJECTIVES Understated executive dysfunction (UED) is predictive of cognitive decline and death. We aimed to assess the prevalence of UED, assessed with the clock-drawing test (CDT) and the Frontal Assessment Battery (FAB) in middle-aged adults and to investigate associated characteristics. METHODS Cross-sectional analysis of data on 516 community-dwellers aged 50-65, lacking cognitive complaints, who were included prospectively (2010-2017) after a multidimensional geriatric assessment at a "healthy ageing" outpatient clinic. Age- and educational-level-adjusted logistic models were used to assess factors associated with UED. RESULTS The CDT and FAB were impaired in 27.7% and 14.7% of the participants (median age: 59.7 years). The prevalence [95% confidence interval (CI)] of UED was 36.2% [32.2-40.5%]. After adjustment for age and education, participants with UED were more likely to be obese (odds ratio [95%CI] = 1.89 [1.12-3.19], P = 0.02), and to have a metabolic syndrome (1.98 [1.06-3.72], P = 0.03). CONCLUSION More than one third of middle-aged adults without cognitive complaints have UED, which was linked to obesity and metabolic syndrome. Cognitive screening tests targeting executive functions might be useful for early detection of UED and the initiation of multidomain interventions improving cognitive performance.
Collapse
Affiliation(s)
- Lauriane Segaux
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.,AP-HP, Hôpital Henri-Mondor, Clinical Research Unit (URC Mondor), Creteil, France
| | - Nadia Oubaya
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.,Department of Public Health, AP-HP, Hôpital Henri-Mondor, Creteil, France
| | - Claire Leissing-Desprez
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.,Department of Geriatric Medicine, AP-HP, Hôpital Emile Roux, Limeil-Brevannes, France
| | - Laurent Cleret De Langavant
- Département d'Etudes Cognitives, École normale supérieure, PSL Research University, Paris, France.,Univ Paris Est Creteil, INSERM, IMRB, Equipe NeuroPsychologie Interventionnelle, Creteil, France.,AP-HP, Hôpital Henri Mondor, Centre de référence Maladie de Huntington, Department of Neurology, Creteil, France
| | - Amaury Broussier
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.,Department of Geriatric Medicine, AP-HP, Hôpital Emile Roux, Limeil-Brevannes, France
| | - Henri Naga
- Department of Geriatric Medicine, AP-HP, Hôpital Emile Roux, Limeil-Brevannes, France
| | - Isabelle Fromentin
- Department of Geriatric Medicine, AP-HP, Hôpital Emile Roux, Limeil-Brevannes, France
| | - Jean-Philippe David
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.,Department of Geriatric Medicine, AP-HP, Hôpital Henri-Mondor, Creteil, France
| | - Sylvie Bastuji-Garin
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.,Department of Public Health, AP-HP, Hôpital Henri-Mondor, Creteil, France
| |
Collapse
|
7
|
Touma J, Couture T, Davaine JM, de Boissieu P, Oubaya N, Michel C, Cochennec F, Chiche L, Desgranges P. Mycotic/Infective Native Aortic Aneurysms: Results After Preferential Use of Open Surgery and Arterial Allografts. Eur J Vasc Endovasc Surg 2021; 63:475-483. [PMID: 34872811 DOI: 10.1016/j.ejvs.2021.10.041] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 09/20/2021] [Accepted: 10/09/2021] [Indexed: 11/03/2022]
Abstract
OBJECTIVE Mycotic/infective native aortic aneurysms (INAA) are managed heterogeneously. In the context of disparate literature, this study aimed to assess the outcomes of INAA surgical management and provide comprehensive data in alignment with recent suggestions for reporting standards. METHODS A retrospective review of patients presenting with INAA from September 2002 to March 2020 at two institutions was conducted. In hospital mortality, 90 day mortality, overall mortality, and infection related complications (IRCs) were the study endpoints. Overall survival and IRC free survival were estimated, and predictors of mortality tested using uni- and multivariable analyses. RESULTS Seventy patients (60 men [86%], median age 68 years [range 59 - 76 years]) were included. Twenty (29%) were ruptured at presentation. INAA location was thoracic in 11 (16%) cases, thoraco-abdominal in seven (10%), and abdominal in 50 (71%). Half of the abdominal INAAs were suprarenal. Two INAAs were concomitantly abdominal and thoracic. Pathogens were identified in 83%. The bacterial spectrum was scattered, with rare Salmonella species (n = 6; 9%). Open surgical repair was performed in 66 (94%) patients, including five conversions of initially attempted endovascular grafts (EVAR), three hybrid procedures, and one palliative EVAR. Vascular substitutes were cryopreserved arterial allografts (n = 67; 96%), prosthesis (n = 2), or femoral veins (n = 1). Kaplan-Meier estimates of overall survival at 30 and 90 days were 87% (95% confidence interval [CI] 76.6 - 93.0) and 71.7% (95% CI 59.2 - 80.9), respectively. The overall in hospital mortality rate was 27.9% (95% CI 1.8 - 66.5). IRCs occurred in seven (10%) patients. The median follow up period was 26.5 months (range 13.0-66.0 months). Chronic kidney disease (CKD) was independently related to in hospital mortality (odds ratio [OR] 20.7, 95% CI 1.8 - 232.7). American Society of Anesthesiologists score of 3 (OR 6.0, 95% CI 1.1 - 33.9), 4 (OR 14.9, 95% CI 1.7 - 129.3), and CKD (OR 32.0, 95% CI 1.2 - 821.5) were related to 90 day mortality. CONCLUSION Surgical INAA management has significant mortality and a low re-infection rate. EVAR necessitated secondary open repair, but its limited use in this report did not allow conclusions to be drawn.
Collapse
Affiliation(s)
- Joseph Touma
- AP-HP, Henri Mondor University Hospital, Vascular surgery department, Creteil, France; Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.
| | - Thibault Couture
- AP-HP, La Pitié-Salpêtrière University Hospital, Vascular Surgery Department, Paris, France
| | - Jean-Michel Davaine
- AP-HP, La Pitié-Salpêtrière University Hospital, Vascular Surgery Department, Paris, France; Sorbonnes Universités UPMC Univ Paris 06, UMRS 1138, Centre de recherche des Cordeliers, Paris, France
| | - Paul de Boissieu
- AP-HP, Bicêtre University Hospital, Epidemiology and Public Health department, Le Kremlin Bicêtre, France
| | - Nadia Oubaya
- Univ Paris Est Creteil, INSERM, IMRB, Creteil, France; AP-HP, Henri Mondor University Hospital, Department of Public Health, Creteil, France
| | - Cassandre Michel
- AP-HP, Henri Mondor University Hospital, Vascular surgery department, Creteil, France
| | - Frédéric Cochennec
- AP-HP, Henri Mondor University Hospital, Vascular surgery department, Creteil, France
| | - Laurent Chiche
- AP-HP, La Pitié-Salpêtrière University Hospital, Vascular Surgery Department, Paris, France
| | - Pascal Desgranges
- AP-HP, Henri Mondor University Hospital, Vascular surgery department, Creteil, France
| |
Collapse
|
8
|
Valter R, Paillaud E, Boudou-Rouquette P, Oubaya N, Aregui A, Lorisson E, Brain E, Rochette de Lempdes G, Laurent M, Canouï-Poitrine F, Martinez-Tapia C. Comparison of the prognostic values of nutrition-related screening tools in older patients with cancer: a prospective multicenter study. J Geriatr Oncol 2021. [DOI: 10.1016/s1879-4068(21)00447-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
9
|
Hebert N, Rakotoson MG, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P. Quantification de l’hémoglobine fœtale dans des globules rouges individualisés. Transfus Clin Biol 2021. [DOI: 10.1016/j.tracli.2021.08.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
10
|
Mézière A, Oubaya N, Michel-Pellegrino V, Boudin B, Neau M, Robert H, Cara I, Salgado Sanchez L, Baloul S, Piette F, Pautas E, Picou Y, Curtis V, Schonheit C, Canouï-Poitrine F, Moreau C. Exercise Interventions With Trained Home Helpers for Preventing Loss of Autonomy and Falls in Community-Dwelling Older Adults Receiving Home Heath Physical Therapy T4H: A Randomized Controlled Pilot Study. J Geriatr Phys Ther 2021; 44:E138-E149. [PMID: 33534333 DOI: 10.1519/jpt.0000000000000287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND AND PURPOSE Older adults at risk for falls live independently in the community in their own home and have rehabilitation needs. However, little is known about whether home coaching of older adults can decrease falls at home. We sought to determine whether a novel program for preventing falls and a loss of exercise capacity, the T4H program, in which home helpers act as exercise coaches by using an information technology (IT) device, was acceptable and feasible. METHODS Between February 2015 and October 2015, we performed a cluster randomized controlled trial in which home helpers either assisted older adults 75 years and over, to participate in the T4H program, or provided standard home help over 3 months. We assessed levels of acceptability and satisfaction among the older adults and home helpers with regard to the exercise program and the technologies used. To measure efficacy, the main outcome measures for the older adults were the absence of falls requiring medical or paramedical care, unplanned hospitalizations, walking ability in a Timed Up and Go test (TUG), and self-care ability by the Barthel Index at the 3-month follow-up visit. RESULTS AND DISCUSSION Overall, 35 older adults were included, aged 89 years and with 68.6% women. Eighty-five percent of the respondents were pleased or very pleased to have participated in the T4H exercise program, 70% were satisfied with the IT devices, and 92% were satisfied with their home helper's level of involvement. Two of the 4 home helper respondents were satisfied or very satisfied with the exercise program, and 2 were moderately satisfied. The proportions of older adult participants with no falls or no unplanned hospitalizations were higher in the T4H group (92.3% and 85.7%, respectively) than in the control group (81.8% and 71.4%, respectively), although these intergroup differences were not statistically significant. The T4H and control groups did not differ significantly with regard to the TUG time (median [IQR]: 27.6 seconds [17.9-58.6] vs 30.7 seconds [19.7-57.2], respectively) or the Barthel Index (median [IQR]: 90 [75-95] and 90 [75-95], respectively). CONCLUSIONS The novel T4H home help model was feasible and was associated with a high level of participant satisfaction. We observed a trend toward fewer falls and hospitalizations and better quality of life in the older adults.
Collapse
Affiliation(s)
- Anthony Mézière
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Nadia Oubaya
- Groupe Hospitalier Universitaire Henri Mondor, Service de Santé Publique, Créteil, France
- Faculty of Medicine, UPEC University, DHU A-TVB, IMRB, CEpiA, Créteil, France
| | | | | | - Marine Neau
- Médialis, Centre d'Evaluation, Fontenay-sous-Bois, France
| | - Hervé Robert
- Ages & Vie, Association de Maintien à Domicile des Personnes Âgées, Vitry sur Seine, France
| | - Isabelle Cara
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Laura Salgado Sanchez
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Samia Baloul
- Groupe Hospitalier Universitaire Henri Mondor, URC-Mondor, Créteil, France
| | - François Piette
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Eric Pautas
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Yannick Picou
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Valentine Curtis
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Claire Schonheit
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| | - Florence Canouï-Poitrine
- Groupe Hospitalier Universitaire Henri Mondor, Service de Santé Publique, Créteil, France
- Faculty of Medicine, UPEC University, DHU A-TVB, IMRB, CEpiA, Créteil, France
| | - Caroline Moreau
- Groupe Hospitalier Universitaire La Pitié Salpêtrière-Charles Foix, site Charles Foix, Gériatrie, Ivry sur Seine, France
| |
Collapse
|
11
|
Segaux L, Broussier A, Oubaya N, Leissing-Desprez C, Laurent M, Naga H, Fromentin I, David JP, Bastuji-Garin S. Several frailty parameters highly prevalent in middle age (50-65) are independent predictors of adverse events. Sci Rep 2021; 11:8774. [PMID: 33888851 PMCID: PMC8062562 DOI: 10.1038/s41598-021-88410-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Accepted: 04/09/2021] [Indexed: 12/26/2022] Open
Abstract
Although frailty can arise in middle age, very few studies have investigated frailty before 65 years. Our objectives were to assess the prevalence of frailty parameters in middle-aged individuals and probe the association with future adverse events. We performed cross-sectional and longitudinal analyses of community-dwelling individuals aged 50 to 65 (n = 411, median age: 59.0) having undergone a multidomain geriatric assessment (2010–2015) in an outpatient clinic in the greater Paris area of France (SUCCEED cohort). The primary outcome was a composite measure of adverse events (non-accidental falls, fractures, unplanned hospitalizations, death), recorded in 2016/2017. Multivariable logistic regression models were built to identify independent predictors. Six frailty parameters were highly prevalent (> 20%): low activity (40.1%), exhaustion (31.3%), living alone (28.5%), balance impairment (26.8%), weakness (26.7%), and executive dysfunction (23.2%). Female sex (odds ratio: 2.67 [95% confidence interval: 1.17–6.11]), living alone (2.39 [1.32–4.33]), balance impairment (2.09 [1.16–3.78]), executive dysfunction (2.61, [1.18–5.77]), and exhaustion (2.98 [1.65–5.39]) were independent predictors of adverse events. Many frailty parameters are already altered in middle-aged individuals and are predictive of adverse health events. Our findings highlight a possible need for frailty screening and preventive programs targeting middle-aged individuals.
Collapse
Affiliation(s)
- Lauriane Segaux
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France. .,Clinical Research Unit (URC Mondor), AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil Cedex, France.
| | - Amaury Broussier
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94450, Limeil-Brévannes, France
| | - Nadia Oubaya
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.,Department of Public Health, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France
| | - Claire Leissing-Desprez
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94450, Limeil-Brévannes, France
| | - Marie Laurent
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94450, Limeil-Brévannes, France
| | - Henri Naga
- Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94450, Limeil-Brévannes, France
| | - Isabelle Fromentin
- Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94450, Limeil-Brévannes, France
| | - Jean-Philippe David
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France.,Departments of Geriatric Medicine, AP-HP, Hôpitaux Henri-Mondor, 94450, Limeil-Brévannes, France
| | - Sylvie Bastuji-Garin
- Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.,Clinical Research Unit (URC Mondor), AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil Cedex, France.,Department of Public Health, AP-HP, Hôpitaux Henri-Mondor, 94010, Creteil, France
| |
Collapse
|
12
|
Afach S, Evrenoglou T, Oubaya N, Le Cleach L, Sbidian E. Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments. J Clin Epidemiol 2021; 133:72-79. [PMID: 33482295 DOI: 10.1016/j.jclinepi.2021.01.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2020] [Revised: 01/11/2021] [Accepted: 01/19/2021] [Indexed: 11/19/2022]
Abstract
BACKGROUND The availability of effective treatments for psoriasis raises ethical questions about the use of a placebo group in therapeutic trials. We evaluated the use of the placebo over time in such trials. METHODS From trials in a living Cochrane review and network meta-analysis for psoriasis, we included trials comparing a biologic to a placebo or other systemic treatment. First, we tested the changes in placebo rate from 2001 to 2019 by linear regression, then constructed networks for 2004-2019 and evaluated the contribution of the placebo to the network meta-analysis estimates per trial and per comparison. RESULTS We included 81 trials (36,774 patients). The placebo rate did not decrease significantly over time. The proportion contribution of trials with a placebo decreased from 100% in 2004 to 86% in 2008 and 75% in 2019. However, the proportion contribution of trials without a placebo remained low (from 0% in 2004 to 25% in 2019). CONCLUSION The design of future psoriasis trials should be reviewed to improve the number of patients to be included in a placebo group.
Collapse
Affiliation(s)
- Sivem Afach
- University Paris Est Créteil, UPEC, EpiDermE EA 7379, F-94010 Créteil, France
| | - Theodoros Evrenoglou
- University of Paris, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS-UMR1153), Inserm, Inra, F-75004 Paris, France
| | - Nadia Oubaya
- University Paris-Est Créteil, UPEC, CEpiA EA 7376, F-94010 Créteil, France; AP-HP, Hôpitaux universitaires Henri Mondor, Department of Dermatology, UPEC, F-94010 Créteil, France
| | - Laurence Le Cleach
- University Paris Est Créteil, UPEC, EpiDermE EA 7379, F-94010 Créteil, France; AP-HP, Hôpitaux universitaires Henri Mondor, Department of Dermatology, UPEC, F-94010 Créteil, France
| | - Emilie Sbidian
- University Paris Est Créteil, UPEC, EpiDermE EA 7379, F-94010 Créteil, France; AP-HP, Hôpitaux universitaires Henri Mondor, Department of Dermatology, UPEC, F-94010 Créteil, France; INSERM, Clinical Investigation Center 1430, F-94010 Créteil, France.
| |
Collapse
|
13
|
Hebert N, Rakotoson MG, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease. Am J Hematol 2020; 95:1235-1245. [PMID: 32681733 DOI: 10.1002/ajh.25937] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Revised: 07/06/2020] [Accepted: 07/10/2020] [Indexed: 02/04/2023]
Abstract
Polymerization of the sickle hemoglobin (HbS) is a key determinant of sickle cell disease (SCD), an inherited blood disorder. Fetal hemoglobin (HbF) is a major modulator of the disease severity by both decreasing HbS intracellular concentration and inhibiting its polymerization. However, heterocellular distribution of HbF is common in SCD. For HbS polymerization inhibition, the hypothesis of an "HbF per red blood cell (HbF/RBC) threshold" requires accurate measurement of HbF in individual RBC. To date, HbF detection methods are limited to a qualitative measurement of RBC populations containing HbF - the F cells, which are variable. We developed an accurate method for HbF quantification in individual RBC. A linear association between mean HbF content and mean RBC fluorescence by flow cytometry, using an anti-Human-HbF antibody, was obtained from non-SCD subjects presenting homogeneous HbF distribution. This correlation was then used to measure HbF/RBC. Hydroxyurea (HU) improves SCD clinical manifestations, mainly through its ability to induce HbF synthesis. The HbF distribution was analyzed in 14 SCD patients before and during HU treatment. A significant decrease in RBC population containing less than 2 pg of HbF/RBC was observed. Therefore, we tested associations for %RBC above different HbF/RBC thresholds and showed a decrease in the pathognomonic vaso-occlusive crisis incidence from the threshold of 4 pg. This quantity was also correlated with the level of sickle RBC after in vitro deoxygenation. This new method allows the comparison of HbF/RBC distributions and could be a useful tool to characterize baseline patients HbF distribution and therapeutic response to HbF inducers.
Collapse
Affiliation(s)
- Nicolas Hebert
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Marie Georgine Rakotoson
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
| | - Gwellaouen Bodivit
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Etienne Audureau
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Laura Bencheikh
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Laurent Kiger
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Nadia Oubaya
- Hôpital Henri Mondor Assistance Publique‐Hôpitaux De Paris (APHP), Université Paris‐Est Créteil Créteil France
| | - Sadaf Pakdaman
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Mehdi Sakka
- Hôpital Henri Mondor Assistance Publique‐Hôpitaux De Paris (APHP), Université Paris‐Est Créteil Créteil France
| | - Gaetana Di Liberto
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Philippe Chadebech
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Benoit Vingert
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - France Pirenne
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Frédéric Galactéros
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Marie Cambot
- UMR_S1134, Université Sorbonne Paris Cité, Université Paris Diderot, Inserm, INTS, Unité Biologie Intégrée du Globule Rouge, Laboratory of excellence LABEX GRex Paris France
| | - Pablo Bartolucci
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| |
Collapse
|
14
|
Laurent M, Oubaya N, David JP, Engels C, Canoui-Poitrine F, Corsin L, Liuu E, Audureau E, Bastuji-Garin S, Paillaud E. Functional decline in geriatric rehabilitation ward; is it ascribable to hospital acquired infection? A prospective cohort study. BMC Geriatr 2020; 20:433. [PMID: 33121435 PMCID: PMC7597031 DOI: 10.1186/s12877-020-01813-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Accepted: 09/30/2020] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND In some European countries, including France, older patients with functional decline in acute units are transferred to geriatric rehabilitation units. Some patients may not benefit from their stay in a geriatric rehabilitation unit and paradoxically worsened their functional status. Previous prognostic models of functional decline are based on only baseline parameters. However, some events can occur during rehabilitation and modify the association between baseline parameters and rehabilitation performance such as heart failure episode, falls or hospital-acquired infection (HAI). The incidence of functional decline in these units and factors associated with this decline have not been clearly identified. METHODS We used a prospective cohort of consecutive patients aged ≥75 years admitted to a geriatric rehabilitation unit in a French university hospital. The main endpoint was functional decline defined by at least an one-point decrease in Activities of Daily Living (ADL) score during the stay. Baseline social and geriatric characteristics were recorded and comorbidities were sought by the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). During follow-up, hospital-acquired infection (HAI) was recorded, as was ADL score at discharge. Multivariate logistic regression and mediation analyses were used to identify factors associated with ADL decrease. RESULTS Among the 252 eligible patients, 160 (median age 84 years [interquartile range (IQR) 80-88] had available ADL scores at baseline (median score 7 [IQR 4-10]) and at discharge (median 9 [6-12]). Median CIRS-G score was 11 [8-13], 23 (14%) had a pulmonary HAI; 28 (17.5%) showed functional decline. On multivariable analysis, functional decline was associated with comorbidities (global CIRS-G score, P = 0.02, CIRS-G for respiratory disease [CIRS-G-R] ≥2, P = 0.02, or psychiatric disease, P = 0.02) and albumin level < 35 g/l (p = 0.03). Significant associations were found between functional decline and CIRS-G-R (OR 3.07 [95%CI 1.27-7.41], p = 0.01), between functional decline and pulmonary HAI (OR 3.12 [1.17-8.32],p = 0.02), and between CIRS-G-R and pulmonary HAI (OR 12.9[4.4-37.7], p = 0.0001). Theses associations and the reduced effect of CIRS-G-R on functional decline after adjusting for pulmonary HAI (OR 2.26 [0.83-6.16], p = 0.11) suggested partial mediation of pulmonary HAI in the relation between CIRS-G-R and functional decline. CONCLUSION Baseline comorbidities were independently associated with functional decline in patients hospitalized in a geriatric rehabilitation unit. Pulmonary HAI may have mediated this association. We need to better identify patients at risk of functional decline before transfer to a rehabilitation unit and to test the implementation of modern and individual programs of rehabilitation outside the hospital for these patients.
Collapse
Affiliation(s)
- Marie Laurent
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France. .,AP-HP, Hopital Henri Mondor, Departement de médecine interne et gériatrie, F-94010, Creteil, France.
| | - Nadia Oubaya
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Service de Santé Publique, AP-HP, Hôpital Henri Mondor, F- 94010, Creteil, France
| | - Jean-Philippe David
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Service de Gériatrie, AP-HP, Hôpital Emile Roux, F- 94450, Limeil Brévannes, France
| | - Cynthia Engels
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Univ Paris Est Creteil, Occupational Therapy Institute (IFE), F -94010, Creteil, France
| | - Florence Canoui-Poitrine
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Service de Santé Publique, AP-HP, Hôpital Henri Mondor, F- 94010, Creteil, France
| | - Lola Corsin
- AP-HP, Hopital Henri Mondor, Departement de médecine interne et gériatrie, F-94010, Creteil, France
| | - Eveline Liuu
- CHU de Poitiers, Service de gériatrie, 2, rue de la Milétrie, F-86021, Poitiers, France
| | - Etienne Audureau
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Service de Santé Publique, AP-HP, Hôpital Henri Mondor, F- 94010, Creteil, France
| | - Sylvie Bastuji-Garin
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Service de Santé Publique, AP-HP, Hôpital Henri Mondor, F- 94010, Creteil, France
| | - Elena Paillaud
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, F-94010, Creteil, France.,Service de Gériatrie, AP-HP, Hôpital Europeen Georges Pompidou, F-75015, Paris, France
| |
Collapse
|
15
|
Ghosn M, Derbel H, Kharrat R, Oubaya N, Mulé S, Chalaye J, Regnault H, Amaddeo G, Itti E, Luciani A, Kobeiter H, Tacher V. Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Diagn Interv Imaging 2020; 102:35-44. [PMID: 33012693 DOI: 10.1016/j.diii.2020.09.004] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 08/20/2020] [Accepted: 09/07/2020] [Indexed: 12/17/2022]
Abstract
PURPOSE To evaluate the potential of imaging criteria in predicting overall survival of patients with hepatocellular carcinoma (HCC) after a first transcatheter arterial yttrium-90 radioembolization (TARE) MATERIALS AND METHODS: From October 2013 to July 2017, 37 patients with HCC were retrospectively included. There were 34 men and 3 women with a mean age of 60.5±10.2 (SD) years (range: 32.7-78.9 years). Twenty-five patients (68%) were Barcelona Clinic Liver Cancer (BCLC) C and 12 (32%) were BCLC B. Twenty-four primary index tumors (65%) were>5cm. Three radiologists evaluated tumor response on pre- and 4-7 months post-TARE magnetic resonance imaging or computed tomography examinations, using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, modified RECIST (mRECIST), European Association for Study of the Liver (EASL), volumetric RECIST (vRECIST), quantitative EASL (qEASL) and the Liver Imaging Reporting and Data System treatment response algorithm. Kaplan-Meier survival curves were used to compare responders and non-responders for each criterion. Univariate and multivariate Cox proportional hazard ratio (HR) analysis were used to identify covariates associated with overall survival. Fleiss kappa test was used to assess interobserver agreement. RESULTS At multivariate analysis, RECIST 1.1 (HR: 0.26; 95% confidence interval [95% CI]: 0.09-0.75; P=0.01), mRECIST (HR: 0.22; 95% CI: 0.08-0.59; P=0.003), EASL (HR: 0.22; 95% CI: 0.07-0.63; P=0.005), and qEASL (HR: 0.30; 95% CI: 0.12-0.80; P=0.02) showed a significant difference in overall survival between responders and nonresponders. RECIST 1.1 had the highest interobserver reproducibility. CONCLUSION RECIST and mRECIST seem to be the best compromise between reproducibility and ability to predict overall survival in patients with HCC treated with TARE.
Collapse
Affiliation(s)
- M Ghosn
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France.
| | - H Derbel
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, équipe 18, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| | - R Kharrat
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - N Oubaya
- Public Health Department, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - S Mulé
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, équipe 18, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| | - J Chalaye
- Department of Nuclear Medicine, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du-Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - H Regnault
- Department of Hepatology, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, équipe 18, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| | - G Amaddeo
- Department of Hepatology, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, équipe 18, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| | - E Itti
- Department of Nuclear Medicine, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du-Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - A Luciani
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, équipe 18, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| | - H Kobeiter
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, Équipe 8, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| | - V Tacher
- Department of Medical Imaging, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Unité Inserm 955, équipe 18, IMRB, University of Paris Est Créteil, 94010 Créteil, France
| |
Collapse
|
16
|
Martinez-Tapia C, Diot T, Oubaya N, Paillaud E, Poisson J, Gisselbrecht M, Morisset L, Caillet P, Baudin A, Pamoukdjian F, Broussier A, Bastuji-Garin S, Laurent M, Canouï-Poitrine F. The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. Am J Clin Nutr 2020; 113:nqaa238. [PMID: 32889525 DOI: 10.1093/ajcn/nqaa238] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Accepted: 07/27/2020] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Overweight and obesity are associated with adverse health outcomes. However, substantial literature suggests that they are associated with longer survival among older people. This "obesity paradox" remains controversial. In the context of cancer, the association between overweight/obesity and mortality is complicated by concomitant weight loss (WL). Sex differences in the relation between BMI (in kg/m2) and survival have also been observed. OBJECTIVES We studied whether a high BMI was associated with better survival, and whether the association differed by sex, in older patients with cancer. METHODS We studied patients aged ≥70 y from the ELCAPA (Elderly Cancer Patients) prospective open cohort (2007-2016; 10 geriatric oncology clinics, Greater Paris urban area). The endpoints were 12- and 60-mo mortality. We created a variable combining BMI at cancer diagnosis and WL in the previous 6 mo, and considered 4 BMI categories-underweight (BMI < 22.5), normal weight (BMI = 22.5-24.9), overweight (BMI = 25-29.9), and obesity (BMI ≥ 30)-and 3 WL categories-<5% (minimal), 5% to <10% (moderate), and ≥10% (severe). Univariate and multivariate Cox proportional hazards analyses were conducted in men and women. RESULTS A total of 2071 patients were included (mean age: 81 y; women: 48%; underweight: 30%; normal weight: 23%; overweight: 33%; obesity: 14%; predominant cancer sites: colorectal (18%) and breast (16%); patients with metastases: 49%). By multivariate analysis, obese women with WL < 5% had a lower 60-mo mortality risk than normal-weight women with WL < 5% (adjusted HR: 0.56; 95% CI: 0.37, 0.86; P = 0.012). Overweight/obese women with WL ≥ 5% did not have a lower mortality risk than normal-weight women with WL < 5%. Overweight and obese men did not have a lower mortality risk, irrespective of WL. CONCLUSIONS By taking account of prediagnosis WL, only older obese women with cancer with minimal WL had a lower mortality risk than their counterparts with normal weight.This trial was registered at clinicaltrials.gov as NCT02884375.
Collapse
Affiliation(s)
- Claudia Martinez-Tapia
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
| | - Thomas Diot
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
| | - Nadia Oubaya
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Public Health Department, Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital, Créteil, France
| | - Elena Paillaud
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Geriatric Department, Public Assistance-Paris Hospitals (AP-HP), Georges-Pompidou European Hospital (HEGP), Paris, France
| | - Johanne Poisson
- Geriatric Department, Public Assistance-Paris Hospitals (AP-HP), Georges-Pompidou European Hospital (HEGP), Paris, France
| | - Mathilde Gisselbrecht
- Onco-Geriatric Department, Public Assistance-Paris Hospitals (AP-HP), Georges-Pompidou European Hospital (HEGP), Paris, France
| | - Laure Morisset
- Oncogeriatrics Coordination Unit, Curie Institute, Paris, France
| | - Philippe Caillet
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Geriatric Department, Public Assistance-Paris Hospitals (AP-HP), Georges-Pompidou European Hospital (HEGP), Paris, France
| | - Aurélie Baudin
- Clinical Research Unit (URC Mondor), Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital, Créteil, France
| | - Fréderic Pamoukdjian
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Coordination Unit in Geriatric Oncology, Geriatric Department, Public Assistance-Paris Hospitals (AP-HP), Avicenne Hospital, Bobigny, France
| | - Amaury Broussier
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Department of Geriatrics, Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital/Emile Roux Hospital, Créteil, France
| | - Sylvie Bastuji-Garin
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Public Health Department, Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital, Créteil, France
- Clinical Research Unit (URC Mondor), Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital, Créteil, France
| | - Marie Laurent
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Internal Medicine and Geriatric Department, Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital, Créteil, France
| | - Florence Canouï-Poitrine
- IMRB-EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Paris-Est Créteil University (UPEC), Créteil, France
- Public Health Department, Public Assistance-Paris Hospitals (AP-HP), Henri-Mondor Hospital, Créteil, France
| |
Collapse
|
17
|
Rwabihama JP, Belmin J, Rakotoarisoa DR, Hagege M, Audureau E, Benzengli H, Ambime G, Rabus MT, Bastuji-Garin S, Paillaud E, Oubaya N. Promoting patients' rights at the end of life in a geriatric setting in France: The healthcare professionals' level of knowledge about surrogate decision-makers and advance directives. Patient Educ Couns 2020; 103:1390-1398. [PMID: 32070651 DOI: 10.1016/j.pec.2020.01.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2019] [Revised: 01/24/2020] [Accepted: 01/29/2020] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To assess levels of knowledge about patients' rights, surrogate decision-makers, and advance directives among healthcare professionals at three hospitals in France. METHODS A multicenter, cross-sectional study in three geriatric hospitals in the Paris area (France) in 2015. The participants' level of knowledge was assessed via an 18-item self-questionnaire on surrogate decision-makers, advance directives, and end-of-life decision-making. The characteristics associated with a good level of knowledge were assessed using logistic regression. RESULTS Among the 301 healthcare professionals (median ± standard deviation age: 40.4 ± 10.2 years; women: 73.4 %), only 15.0 % (95 % confidence interval (CI): [19.7-29.5]) correctly answered at least 75 % of the questions on patients' rights. Respectively 24.6 % [19.7-29.5], 36.5 % [31.1-42.0] and 37.5 % [32.0-43.0] had sufficient knowledge regarding "surrogate decision-maker", "advance directives", and "decision-making at the end of life". In a multivariable analysis, the only factor significantly associated with a good level of knowledge about end-of-life policy was employment in a university hospital, with a non-significant trend for status as a physician. CONCLUSIONS Our survey of staff working in geriatric care units highlighted the poor overall level of knowledge about healthcare surrogates and advance directives; the results suggest that additional training in these concepts is required. PRACTICE IMPLICATIONS Continuing education of healthcare professionals on advance directives and surrogate decision-maker should be promoted to ensure rights of elderly patients at the end of life.
Collapse
Affiliation(s)
- Jean Paul Rwabihama
- Inserm U955, Université Paris Est Créteil (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), équipe CEpiA (Clinical Epidemiology and Ageing), Créteil, France; Assistance Publique-Hôpitaux de Paris, Joffre-Dupuytren Hospital, Geriatric Department, Draveil, F- 91210, France.
| | - Joël Belmin
- Assistance Publique-Hôpitaux de Paris, Charles Foix Hospital, Geriatric Department, Ivry-sur-seine, F- 94200, France
| | - De Rozier Rakotoarisoa
- Assistance Publique-Hôpitaux de Paris, George Clemenceau Hospital, Geriatric Department, Champceuil, F- 91750, France
| | - Meoïn Hagege
- Inserm U955, Université Paris Est Créteil (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), équipe CEpiA (Clinical Epidemiology and Ageing), Créteil, France
| | - Etienne Audureau
- Inserm U955, Université Paris Est Créteil (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), équipe CEpiA (Clinical Epidemiology and Ageing), Créteil, France; Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Department of Public Health, Créteil, F- 94000, France
| | - Hind Benzengli
- Assistance Publique-Hôpitaux de Paris, Joffre-Dupuytren Hospital, Pharmacy Department, Draveil, F- 91210, France
| | - Gabin Ambime
- Assistance Publique-Hôpitaux de Paris, Joffre-Dupuytren Hospital, Geriatric Department, Draveil, F- 91210, France
| | - Marie-Thérèse Rabus
- Assistance Publique-Hôpitaux de Paris, Joffre-Dupuytren Hospital, Geriatric Department, Draveil, F- 91210, France
| | - Sylvie Bastuji-Garin
- Inserm U955, Université Paris Est Créteil (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), équipe CEpiA (Clinical Epidemiology and Ageing), Créteil, France; Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Department of Public Health, Créteil, F- 94000, France
| | - Elena Paillaud
- Inserm U955, Université Paris Est Créteil (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), équipe CEpiA (Clinical Epidemiology and Ageing), Créteil, France; Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Geriatric Departement, Créteil, F- 94000, France
| | - Nadia Oubaya
- Inserm U955, Université Paris Est Créteil (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), équipe CEpiA (Clinical Epidemiology and Ageing), Créteil, France; Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Department of Public Health, Créteil, F- 94000, France
| |
Collapse
|
18
|
Leissing-Desprez C, Thomas E, Segaux L, Broussier A, Oubaya N, Marie-Nelly N, Laurent M, Cleret de Langavant L, Fromentin I, David JP, Bastuji-Garin S. Understated Cognitive Impairment Assessed with the Clock-Drawing Test in Community-Dwelling Individuals Aged ≥50 Years. J Am Med Dir Assoc 2020; 21:1658-1664. [PMID: 32387111 DOI: 10.1016/j.jamda.2020.03.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Revised: 03/13/2020] [Accepted: 03/17/2020] [Indexed: 11/18/2022]
Abstract
OBJECTIVES To estimate the prevalence of understated cognitive impairment by administering the Clock-Drawing Test (CDT) to community-dwelling individuals aged ≥50 years and to investigate the associated clinical phenotype. DESIGN A cross-sectional analysis of baseline data on community-dwelling individuals assessed at an outpatient clinic in the Paris region of France. SETTING AND PARTICIPANTS Participants aged ≥50 years (n = 488, median age: 62.1 years) prospectively included in the SUCCessful agEing outpatiEnt's Department survey between 2010 and 2014. METHODS A multidimensional geriatric assessment, including cognition [7-point CDT, Mini-Mental State Examination (MMSE), the 5-word screening test (5-WT), and the Frontal Assessment Battery (FAB)], gait speed in dual tasks, mood [the Geriatric Depression Scale (GDS)], balance, physical functions (gait speed and handgrip strength), nutrition, bone density, and comorbidities; major cardiovascular risk factors, and Scheltens and Fazekas scores on brain magnetic resonance imaging. Baseline characteristics were analyzed as a function of the CDT score (<7 vs 7), using age-adjusted logistic models. RESULTS The prevalence of impairment in the CDT was 23.6%; higher than the values for the MMSE (12.7%), 5-WT (2.3%), and FAB (16.6%). In age-adjusted analyses, a lower educational level (odds ratio [95% confidence interval] = 0.72 [0.58‒0.89]), diabetes (2.57 [1.14‒5.79]), metabolic syndrome (1.93 [1.05‒3.56]), lower gait speed in the cognitive dual task (1.27 [1.05‒1.53]), a poorer Geriatric Depression Scale score (1.86 [1.04‒3.32]), a poorer MMSE score (2.56 [1.35‒4.88]), a poorer FAB score (1.79 [1.01‒3.16]), impaired episodic memory in the 5-WT (4.11 [1.12‒15.02]), and a higher Scheltens score (P = .001) were significantly associated with CDT impairment. CONCLUSIONS AND IMPLICATIONS Understated cognitive impairment is common among young seniors and is associated with factors known to be linked to a higher risk of cognitive decline and dementia. These findings suggest that the CDT may be of value for identifying high-risk individuals who may then benefit from targeted multidomain prevention actions (diet, exercise, cognitive training, and vascular risk factor management).
Collapse
Affiliation(s)
- Claire Leissing-Desprez
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Department of Geriatric Medecine, Creteil, France.
| | - Emilie Thomas
- AP-HP, Hôpitaux Henri-Mondor, Department of Geriatric Medecine, Creteil, France
| | - Lauriane Segaux
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Clinical Research Unit (URC Mondor), Creteil, France
| | - Amaury Broussier
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Department of Geriatric Medecine, Creteil, France
| | - Nadia Oubaya
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Department of Public Health, Creteil, France
| | | | - Marie Laurent
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Department of Geriatric Medecine, Creteil, France
| | - Laurent Cleret de Langavant
- AP-HP, Hôpitaux Henri-Mondor, Department of Neurology, Creteil, France; INSERM U955 E01, IMRB and ENS-DEC, PSL Research University (NeuroPsychologie Interventionnelle), Creteil and Paris, France
| | - Isabelle Fromentin
- AP-HP, Hôpitaux Henri-Mondor, Department of Geriatric Medecine, Creteil, France
| | - Jean-Philippe David
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Department of Geriatric Medecine, Creteil, France
| | - Sylvie Bastuji-Garin
- Univ Paris Est Creteil, INSERM, IMRB, CEpiA Team, Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Clinical Research Unit (URC Mondor), Creteil, France; AP-HP, Hôpitaux Henri-Mondor, Department of Public Health, Creteil, France
| |
Collapse
|
19
|
Tacher V, Blain M, Hérin E, Vitellius M, Chiaradia M, Oubaya N, Derbel H, Kobeiter H. CBCT-Based Image Guidance for Percutaneous Access: Electromagnetic Navigation Versus 3D Image Fusion with Fluoroscopy Versus Combination of Both Technologies-A Phantom Study. Cardiovasc Intervent Radiol 2019; 43:495-504. [PMID: 31650244 DOI: 10.1007/s00270-019-02356-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/17/2019] [Accepted: 10/10/2019] [Indexed: 10/25/2022]
Abstract
PURPOSE We set out to compare three types of three-dimensional CBCT-based imaging guidance modalities in a phantom study: image fusion with fluoroscopy (IF), electromagnetic navigation (EMN) and the association of both technologies (CEMNIF). MATERIALS AND METHODS Four targets with a median diameter of 11 mm [first quartile (Q1): 10; third quartile (Q3): 12] with acute angle access (z-axis < 45°) and four targets of 10 mm [8-15] with large angle access (z-axis > 45°) were defined on an abdominal phantom (CIRS, Meditest, Tabuteau, France). Acute angle access targets were punctured using IF, EMN or CEMNIF and large angle access targets with EMN by four operators with various experiences. Efficacy (target reached), accuracy (distance between needle tip and target center), procedure time, radiation exposure and reproducibility were explored and compared. RESULTS All targets were reached (100% efficacy) by all operators. For targets with acute angle access, procedure times (EMN: 265 s [236-360], IF: 292 s [260-345], CEMNIF: 320 s [240-333]) and accuracy (EMN: 3 mm [2-5], IF: 2 mm [1-3], CEMNIF: 3 mm [2-4]) were similar. Radiation exposure (EMN: 0; IF: 708 mGy.cm2 [599-1128]; CEMNIF: 51 mGy.cm2 [15-150]; p < 0.001) was significantly higher with IF than with CEMNIF and EMN. For targets with large angle access, procedure times (EMN: 345 s [259-457], CEMNIF: 425 s [340-473]; p = 0.01) and radiation exposure (EMN: 0, CEMIF: 159 mGy.cm2 [39-316]; p < 0.001) were significantly lower with EMN but with lower accuracy (EMN: 4 mm [4-6] and CEMNIF: 4 mm [3, 4]; p = 0.01). The operator's experience did not impact the tested parameters regardless of the technique. CONCLUSION In this phantom study, EMN was not limited to acute angle targets. Efficacy and accuracy of puncture for acute angle access targets with EMN, IF or CEMNIF were similar. CEMNIF is more accurate for large angle access targets at the cost of a slightly higher procedure time and radiation exposure.
Collapse
Affiliation(s)
- Vania Tacher
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France. .,Université Paris-Est Créteil (UPEC), 94010, Créteil, France. .,Unité INSERM U955 #18, IMRB, Créteil, France.
| | - Maxime Blain
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France
| | - Edouard Hérin
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.,Université Paris-Est Créteil (UPEC), 94010, Créteil, France
| | - Manuel Vitellius
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France
| | - Mélanie Chiaradia
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France
| | - Nadia Oubaya
- Service de santé publique, APHP Hôpital Henri Mondor, Créteil, France.,UPEC, DHU A-TVB, IMRB-EA 7376 CEpiA (Clinical Epidemiology And Ageing Unit), Paris-Est University, 94000, Créteil, France
| | - Haytham Derbel
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.,Université Paris-Est Créteil (UPEC), 94010, Créteil, France.,Unité INSERM U955 #18, IMRB, Créteil, France
| | - Hicham Kobeiter
- Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.,Université Paris-Est Créteil (UPEC), 94010, Créteil, France
| |
Collapse
|
20
|
Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R. Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis. Eur J Clin Microbiol Infect Dis 2019; 39:121-129. [DOI: 10.1007/s10096-019-03701-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Accepted: 09/03/2019] [Indexed: 01/22/2023]
|
21
|
Segaux L, Oubaya N, Broussier A, Baude M, Canouï-Poitrine F, Naga H, Laurent M, Leissing-Desprez C, Audureau E, Ferrat E, Chailloleau C, Fromentin I, David JP, Bastuji-Garin S. Identification of five frailty profiles in community-dwelling individuals aged 50-75: A latent class analysis of the SUCCEED survey data. Maturitas 2019; 127:1-11. [PMID: 31351514 DOI: 10.1016/j.maturitas.2019.05.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2018] [Revised: 04/24/2019] [Accepted: 05/13/2019] [Indexed: 11/16/2022]
Abstract
OBJECTIVES We sought to identify frailty profiles in individuals aged 50-75 by considering frailty as an unobservable latent variable in a latent class analysis (LCA). STUDY DESIGN 589 prospectively enrolled community-dwelling individuals aged 50-75 (median: 61.7 years) had undergone a standardized, multidomain assessment in 2010-2015. Adverse health outcomes (non-accidental falls, fractures, unplanned hospitalizations, and death) that had occurred since the assessment were recorded in 2016-2017. MAIN OUTCOME MEASURES The LCA used nine indicators (unintentional weight loss, relative slowness, weakness, impaired balance, osteoporosis, impaired cognitive functions, executive dysfunction, depression, and hearing impairment) and three covariates (age, gender, and consultation for health complaints). The resulting profiles were characterized by the Fried phenotype and adverse health outcomes. RESULTS We identified five profiles: "fit" (LC1, 29.7% of the participants; median age: 59 years); "weight loss, relative slowness, and osteoporosis" (LC2, 33.2%; 63 years); "weakness and osteopenia" (LC3, 21.9%; 60 years); "impaired physical and executive functions" (LC4, 11%; 67 years); and "impaired balance, cognitive functions, and depression" (LC5, 4.3%; 70 years). Almost all members of LC3 and LC4 were female, and were more likely than members of other profiles to have a frail or pre-frail Fried phenotype. Non-accidental falls were significantly more frequent in LC4. LC5 (almost all males) had the highest number of comorbidities and cardiovascular risk factors but none was frail. CONCLUSIONS Our data-driven approach covered most geriatric assessment domains and identified five frailty profiles. With a view to tailoring interventions and prevention, frailty needs to be detected among young seniors.
Collapse
Affiliation(s)
- Lauriane Segaux
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Henri-Mondor, Clinical Research Unit (URC Mondor), Créteil, France.
| | - Nadia Oubaya
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor, Department of Public Health, Créteil, France
| | - Amaury Broussier
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor/Emile Roux, Department of Geriatrics, Créteil, France
| | - Marjolaine Baude
- AP-HP, Hôpital Henri-Mondor, Department of Public Health, Créteil, France
| | - Florence Canouï-Poitrine
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor, Department of Public Health, Créteil, France
| | - Henri Naga
- AP-HP, Hôpital Henri-Mondor/Emile Roux, Department of Geriatrics, Créteil, France
| | - Marie Laurent
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor/Albert Chenevier, Department of Geriatrics, Créteil, France
| | - Claire Leissing-Desprez
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor/Emile Roux, Department of Geriatrics, Créteil, France
| | - Etienne Audureau
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor, Department of Public Health, Créteil, France
| | - Emilie Ferrat
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; UPEC, Faculté de médecine de Créteil, Primary Care Department, Créteil, France
| | | | - Isabelle Fromentin
- AP-HP, Hôpital Henri-Mondor/Emile Roux, Department of Geriatrics, Créteil, France
| | - Jean-Philippe David
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Hôpital Henri-Mondor/Emile Roux, Department of Geriatrics, Créteil, France
| | - Sylvie Bastuji-Garin
- Université Paris Est (UPEC), IMRB, A-TVB DHU, CEpiA EA 7376 (Clinical Epidemiology and Ageing Unit), Créteil, France; Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Henri-Mondor, Clinical Research Unit (URC Mondor), Créteil, France; AP-HP, Hôpital Henri-Mondor, Department of Public Health, Créteil, France
| |
Collapse
|
22
|
Martinez-Tapia C, Diot T, Oubaya N, Paillaud E, Poisson J, Gisselbrecht M, Caillet P, Baudin A, Pamoukdjian F, Bastuji-Garin S, Laurent M, Canoui-Poitrine F. Obesity paradox in older cancer patients for middle and long-term mortality: A prospective multicenter cohort study of 2,071 patients. J Clin Oncol 2019. [DOI: 10.1200/jco.2019.37.15_suppl.11555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11555 Background: Overweight and obesity are associated with numerous adverse health outcomes. However, among older adults, substantial literature suggests an improved survival among overweight and obese patients. This phenomenon, referred to as the “obesity paradox” remains controversial. In the context of cancer, the association between overweight/obesity and mortality is complex due to the concomitant weight loss and cachexia. We aim to assess the impact of high Body Mass Index (BMI) on mortality in a large population of older cancer patients. Methods: We studied patients aged ≥70 from the ELCAPA prospective open-cohort (2007-2016; 10 geriatric oncology clinics, Great Paris urban area). Endpoints were 12- and 48-months mortality. A variable combining BMI at cancer diagnosis and weight loss (in the 6 months preceding the diagnosis) was created. BMI categories considered: underweight, (BMI < 22.4kg/m²), normal weight (BMI 22.5-24.9), overweight (BMI 25-29.9), and obese (BMI ≥30); weight loss (WL) categories: < 5%, 5- < 10%, ≥10%. Univariate and multivariate Cox proportional-hazards analysis were conducted in males and females. Results: A total of 2071 patients were included (mean age, 81; female, 48%; metastases, 49%; main localizations: digestive (37%), urinary (26%), breast (16%); underweight (30%), normal weight (23%), overweight (33%), obese (14%)). After adjustment for age, smoking, inpatient status, cancer site, metastasis, performance status and comorbidities, overweight women with < 5% WL were at lower risk of 12- and 48-months mortality compared to normal weight women with < 5% WL (aHR = 0.56; p = 0.043 and 0.65; p = 0.031, respectively). Obese women with < 5% WL had a lower mortality risk only at 48-months (aHR = 0.63; p = 0.036). The obesity paradox was stronger in overweight metastatic women. Overweight or obese women with 5- < 10% or ≥10% WL had no reduced risk of mortality compared to normal weight women. Overweight and obese men had no reduced risk of mortality irrespective of weight loss. Conclusions: By taking into account initial weight loss, we did not found evidence for obesity paradox in older patients with cancer except in the subgroup of women with minimal weight loss. Clinical trial information: NCT02884375.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Aurélie Baudin
- Unité de Recherche Clinique, Hôpital Henri-Mondor, Créteil, France
| | - Frédéric Pamoukdjian
- Clinical Epidemiology and Aging (CEPIA)-EA7376, UPEC. APHP, Hôpital Avicenne, H.U.P.S.S.D., Bobigny, France
| | | | - Marie Laurent
- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France
| | | |
Collapse
|
23
|
Paillaud E, Soubeyran P, Oubaya N, Brain E, Fonck M, Reinald N, Heitz D, Allain M, Zebachi S, Rousselot H, Laurent M, Dauba J, Caillet P, Bastuji-Garin S, Rainfray M, Bringuier M, Grellety T, Bellera CA, Mathoulin-Pélissier S, Canoui-Poitrine F. Prognostic value of routine biomarkers in older patients with cancer: Pooled analysis of three prospective cohorts. J Clin Oncol 2019. [DOI: 10.1200/jco.2019.37.15_suppl.11551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11551 Background: To assess prognostic value of routine biomarkers in older patients with cancer. Methods: A pooled analysis of three prospective multicentre cohorts, ELCAPA, PHRC Aquitaine and ONCODAGE was conducted. Patients aged 70 years or older, with cancer were included. Biomarkers collected were plasmatic C-reactive protein, albumin and a combined score: Glasgow Prognostic Score (GPS). The GPS comprised three categories (0: CRP≤10 mg/L, albumin≥35 g/L; 1: CRP≤10 mg/L and albumin < 35 g/L, or CRP > 10 mg/L and albumin≥35 g/L; 2: CRP > 10 mg/L and albumin < 35 g/L).The primary endpoint was overall survival at 12 months. Multivariable Cox models were used, adjusting for age, sex, localisation, metastatic status, performance status, frailty screening index, the G8. Discriminative properties were assessed using Harrell C index and NRI (Net Reclassification Improvement). Results: Overall 1800 patients were analyzed (ELCAPA: N = 543, PHRC Aquitaine: N = 253, ONCODAGE: N = 1004; mean age: 78.5±5.5 years; 61.7% of men; 37% metastatic; most frequent localisations: breast (34.9%) and colon-rectum (17.7%); 70.7% of patients screened at risk of frailty with G8). Overall survival was 71.1%. GPS was independently associated with death (among normal G8: GPS 1: Hazard Ratio (HR) = 4.48; 95% Confidence Interval (95% CI) = [2.03; 9.89], GPS 2: 11.64 [4.54; 29.81], among abnormal G8: GPS 1: 2.45 [1.79; 3.34], GPS 2: 3.97 [2.93; 5.37]. The addition of GPS to the clinical model (Harell C: 0.82 [0.80; 0.83]) improved discrimination (Harell C: 0.84 [0.82; 0.85], NRI: 11% [5; 19]). Conclusions: GPS could be used in older patients with cancer to help decision-making and prognosis assessment.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Mylene Allain
- Clinical Research Unit, Henri-Mondor Hospital, Créteil, France
| | - Sonia Zebachi
- Université Paris Est Creteil, Clinical Epidemiology And Ageing, Créteil, France
| | - Hubert Rousselot
- Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-Les-Nancy, France
| | - Marie Laurent
- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France
| | | | | | | | - Muriel Rainfray
- Department of Clinical Gerontology, Bordeaux University Hospital Xavier Arnozan, Pessac, France
| | | | | | | | | | - Florence Canoui-Poitrine
- Assistance Publique–Hôpitaux de Paris, Hopital Mondor-Chenevier, Universite Paris Est, Créteil, France
| |
Collapse
|
24
|
Segaux L, Oubaya N, Broussier A, Canoui-Poitrine F, Audureau E, Fromentin I, David J, Bastuji-Garin S. Identification de cinq profils de fragilité dans une population de sujets âgés de 50 à 75 ans. Une analyse en classe latente (Étude Succeed). Rev Epidemiol Sante Publique 2019. [DOI: 10.1016/j.respe.2019.03.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
25
|
Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, Schmutz JL, Beneton N, Mahé E, Viguier M, Chosidow O, Canoui-Poitrine F, Sbidian E. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol 2018; 32:1920-1929. [PMID: 29729123 DOI: 10.1111/jdv.15044] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2018] [Accepted: 03/28/2018] [Indexed: 11/28/2022]
Abstract
BACKGROUND In the late 2000s, the introduction of biologics transformed the prognosis for patients with moderate-to-severe psoriasis. We hypothesized that treatment with biologics may associate with a reduction in the hospitalization rate for psoriasis flares. OBJECTIVE To analyse changes over time in the hospitalization rate for psoriasis flares. METHODS We included inpatient stays in any of nine French hospitals between 2005 and 2015 for a psoriasis flare, as documented in the national inpatient database. In two centres, we also analysed data from the individual patients' electronic medical records. RESULTS A total of 3572 stays were included. The introduction of biologics was not associated with a decrease in the number of hospitalizations for a psoriasis flare; on the contrary, we observed a non-significant increase in the number of hospitalizations (13 hospitalizations for psoriasis flares per quarter per 10 000 beds). In the two-centre study, the introduction of biologics was associated with a significant increase in the hospitalization of patients receiving topical treatments only (520 hospitalizations per year per 10 000 beds) and those with a first psoriasis flare. CONCLUSION The number of hospitalizations for a psoriasis flare tended to increase between 2005 and 2015. The availability of additional treatment options might have increased patient demand and/or broadened the indications in clinical practice.
Collapse
Affiliation(s)
- L Polivka
- Department of Dermatology, Necker-Enfants Malades Hospital (AP-HP), Paris Descartes-Sorbonne Paris Cité University, Paris, France
| | - N Oubaya
- Department of Clinical Research and Public Health, Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France.,IMRB-EA 7376 CEpiA (Clinical Epidemiology And Ageing Unit), UPEC, DHU A-TVB, Paris-Est University, Créteil, France
| | - H Bachelez
- Department of Dermatology, Saint Louis Hospital (AP-HP), Sorbonne Paris Cité University Paris Diderot, Paris, France
| | - C Paul
- Department of Dermatology, Larrey Hospital, Toulouse University, Toulouse, France
| | - M A Richard
- Dermatology Department, Centre de recherche en oncologie biologique et oncophamacologie', UMR 911, INSERM CRO2, Timone Hospital, Assistance Publique Hôpitaux de Marseille, Aix-Marseille Univ, Marseille, France
| | - M Beylot-Barry
- Department of Dermatology, INSERM 1053, CHU Bordeaux, Bordeaux University, Bordeaux, France
| | - J L Schmutz
- Department of Dermato-Allergology, Brabois Hospital, Nancy University, Vandoeuvre-lès-Nancy, France
| | - N Beneton
- Department of Dermatology, Le Mans General Hospital, Le Mans, France
| | - E Mahé
- Department of Dermatology, Victor Dupouy Hospital, Argenteuil, France
| | - M Viguier
- Department of Dermatology, Robert Debré Hospital, University of Reims-Champagne Ardennes, Reims, France
| | - O Chosidow
- Department of Dermatology, Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France.,Centre d'Investigation Clinique 1430, INSERM, Créteil, France.,UPEC, DHU VIC, EA 7379 EpiDermE (Epidemiologie En Dermatologie et Evaluation des Thérapeutiques), Paris-Est University, Créteil, France
| | - F Canoui-Poitrine
- Department of Clinical Research and Public Health, Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France.,IMRB-EA 7376 CEpiA (Clinical Epidemiology And Ageing Unit), UPEC, DHU A-TVB, Paris-Est University, Créteil, France
| | - E Sbidian
- Department of Dermatology, Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France.,Centre d'Investigation Clinique 1430, INSERM, Créteil, France.,UPEC, DHU VIC, EA 7379 EpiDermE (Epidemiologie En Dermatologie et Evaluation des Thérapeutiques), Paris-Est University, Créteil, France
| | | |
Collapse
|
26
|
Oubaya N, Soubeyran P, Reinald N, Fonck M, Allain M, Heitz D, Laurent M, Rousselot H, Caillet P, Dauba J, Bastuji-Garin S, Albrand G, Bringuier M, Rainfray M, Brain E, Grellety T, Paillaud E, Mathoulin-Pélissier S, Bellera C, Canouï-Poitrine F. Valeur prédictive des biomarqueurs de routine chez les patients âgés atteints de cancer : analyse poolée des cohortes ELCAPA, PHRC Aquitaine et ONCODAGE. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.03.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
27
|
Oubaya N, Dramé M, Novella JL, Quignard E, Cunin C, Jolly D, Mahmoudi R. Screening for frailty in community-dwelling elderly subjects: Predictive validity of the modified SEGA instrument. Arch Gerontol Geriatr 2017; 73:177-181. [PMID: 28822918 DOI: 10.1016/j.archger.2017.07.026] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2016] [Revised: 07/26/2017] [Accepted: 07/27/2017] [Indexed: 11/30/2022]
Abstract
AIMS To study the capacity of the SEGAm instrument to predict loss of independence among elderly community-dwelling subjects. METHODS The study was performed in four French departments (Ardennes, Marne, Meurthe-et-Moselle, Meuse). Subjects aged 65 years or more, living at home, who could read and understand French, with a degree of autonomy corresponding to groups 5 or 6 in the AGGIR autonomy evaluation scale were included. Assessment included demographic characteristics, comprehensive geriatric assessment, and the SEGAm instrument at baseline. Subjects had follow-up visits at home at 6 and 12 months. During follow-up, vital status and level of independence were recorded. Logistic regression was used to study predictive validity of the SEGAm instrument. RESULTS Among the 116 subjects with complete follow-up, 84 (72.4%) were classed as not very frail at baseline, 23 (19.8%) as frail, and 9 (7.8%) as very frail; 63 (54.3%) suffered loss of at least one ADL or IADL at 12 months. By multivariable analysis, frailty status at baseline was significantly associated with loss of independence during the 12 months of follow-up (OR=4.52, 95% CI=1.40-14.68; p=0.01). We previously validated the SEGAm instrument in terms of feasibility, acceptability, internal structure validity, reliability, and discriminant validity. CONCLUSIONS This instrument appears to be a suitable tool for screening frailty among community-dwelling elderly subjects, and could be used as a basis to plan early targeted interventions for subjects at risk of adverse outcome.
Collapse
Affiliation(s)
- N Oubaya
- University of Reims Champagne-Ardenne, Faculty of Medicine, E.A 3797, Reims, F-51095, France
| | - M Dramé
- University of Reims Champagne-Ardenne, Faculty of Medicine, E.A 3797, Reims, F-51095, France; Reims Teaching Hospitals, Robert Debré Hospital, Department of Research and Public Health, Reims, F-51092, France.
| | - J-L Novella
- University of Reims Champagne-Ardenne, Faculty of Medicine, E.A 3797, Reims, F-51095, France; Reims Teaching Hospitals, Maison Blanche Hospital, Department of Geriatrics and Internal Medicine, Reims, F-51092, France
| | - E Quignard
- Hospital of Troyes, Department of Palliative Care, Troyes, F-10003, France
| | - C Cunin
- Caisse d'Assurance retraite et de Santé au travail du Nord-Est, Mission RELAIS - Actions collectives gérontologiques, Nancy, F-54000, France
| | - D Jolly
- University of Reims Champagne-Ardenne, Faculty of Medicine, E.A 3797, Reims, F-51095, France; Reims Teaching Hospitals, Robert Debré Hospital, Department of Research and Public Health, Reims, F-51092, France
| | - R Mahmoudi
- University of Reims Champagne-Ardenne, Faculty of Medicine, E.A 3797, Reims, F-51095, France; Reims Teaching Hospitals, Maison Blanche Hospital, Department of Geriatrics and Internal Medicine, Reims, F-51092, France
| |
Collapse
|
28
|
Gross J, Oubaya N, Eymard F, Hourdille A, Chevalier X, Guignard S. Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case-control study. Scand J Rheumatol 2017; 46:507-508. [PMID: 28766391 DOI: 10.1080/03009742.2017.1324910] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- J Gross
- a Department of Rheumatology , APHP Henri Mondor Hospital , Créteil , France
| | - N Oubaya
- b Department of Public Health , APHP Henri Mondor Hospital , Créteil , France.,c Clinical Epidemiology and Ageing Unit , University of Paris-Est , Créteil , France
| | - F Eymard
- a Department of Rheumatology , APHP Henri Mondor Hospital , Créteil , France
| | - A Hourdille
- a Department of Rheumatology , APHP Henri Mondor Hospital , Créteil , France
| | - X Chevalier
- a Department of Rheumatology , APHP Henri Mondor Hospital , Créteil , France
| | - S Guignard
- a Department of Rheumatology , APHP Henri Mondor Hospital , Créteil , France
| |
Collapse
|
29
|
Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet JM, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier AL, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X. Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis. J Crohns Colitis 2017; 11:930-935. [PMID: 28333202 DOI: 10.1093/ecco-jcc/jjx027] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/27/2016] [Accepted: 02/18/2017] [Indexed: 02/08/2023]
Abstract
BACKGROUND AND AIMS Colectomy can be required in the management of ulcerative colitis [UC]. While ileal-pouch anal anastomosis [IPAA] is the recommended reconstruction technique, ileorectal anastomosis [IRA] is still performed and might present some advantages. However, the risk of rectal neoplasia might limit its indication. The aims of our study were to determine the incidence of rectal neoplasias following IRA for UC and to identify risk factors associated with rectal carcinomas. METHODS We performed a multicenter retrospective study including patients who underwent IRA for UC from 1960 to 2014 in 13 centers. Cox-proportional hazard models were used to determine carcinoma-associated risk factors. RESULTS A total of 343 patients were included, with a median follow-up of 10.4 years after IRA. At the end of follow-up, 38 rectal neoplasias (including 19 carcinomas) were diagnosed, and 7 patients [2%] had either died from rectal carcinoma or had a metastatic disease. Incidences of rectal carcinoma after IRA for UC were estimated at 3.2% at 10 years and at 7.3% at 20 years, whereas incidences of neoplasia were estimated at 7.1% and 14% at 10 and 20 years, respectively. In multivariate analysis, age at IRA, IBD duration, primary sclerosing cholangitis [PSC] and history of prior colonic carcinoma were independently associated with the risk of rectal carcinoma following IRA. CONCLUSION The risk of rectal carcinoma in patients with IRA for UC remains, and this justifies long-term endoscopic surveillance. Either IPAA or end ileostomy should be considered in 'high-risk' patients i.e. those with PSC and/or with prior colonic neoplasia.
Collapse
Affiliation(s)
- Mathieu Uzzan
- Department of Gastroenterology, IBD and Nutritive Assistance, Hôpital Beaujon, APHP, Clichy, France
| | - Julien Kirchgesner
- Department of Gastroenterology, Hôpital Saint Antoine, APHP, Paris, France
| | - Nadia Oubaya
- Department of Epidemiology and Clinical Research, Hôpital Beaujon, APHP, Clichy, France
| | - Aurélien Amiot
- Department of Gastroenterology, Hôpital Henri Mondor APHP, Créteil, France
| | - Jean-Marc Gornet
- Department of Gastroenterology, Hôpital Saint Louis, APHP, Paris, France
| | - Philippe Seksik
- Department of Gastroenterology, Hôpital Saint Antoine, APHP, Paris, France
| | - Stéphane Nancey
- Department of Gastroenterology, CHU Lyon Sud, Pierre-Bénite, France
| | - Eddy Cotte
- Department of Digestive Surgery, CHU Lyon Sud, Pierre-Bénite, France
| | - Matthieu Allez
- Department of Gastroenterology, Hôpital Saint Louis, APHP, Paris, France
| | - Gilles Boschetti
- Department of Gastroenterology, CHU Lyon Sud, Pierre-Bénite, France
| | - David Laharie
- Department of Gastroenterology, Hôpital du Haut-Levêque, CHU Bordeaux, Pessac, France
| | - Nicola de Angelis
- Department of Digestive Surgery, Hôpital Henri Mondor, APHP, Créteil, France
| | - Maria Nachury
- Department of Gastroenterology, CHRU Lille, Lille, France
| | | | - Vered Abitbol
- Department of Gastroenterology, Hôpital Cochin, APHP, Paris, France
| | | | - Antoine Brouquet
- Department of Digestive Surgery, Hôpital du Kremlin-Bicêtre, APHP, France
| | - Anthony Buisson
- Department of Gastroenterology, CHU Estaing, Clermont-Ferrand, France
| | - Romain Altwegg
- Department of Gastroenterology, CHRU Montpellier, Montpellier, France
| | - Jacques Cosnes
- Department of Gastroenterology, Hôpital Saint Antoine, APHP, Paris, France
| | - Yves Panis
- Department of Digestive Surgery, Hôpital Beaujon, APHP, France
| | - Xavier Treton
- Department of Gastroenterology, IBD and Nutritive Assistance, Hôpital Beaujon, APHP, Clichy, France
| |
Collapse
|
30
|
Oubaya N, Drame M, Novella J, Quignard E, Cunin C, Jolly D, Mahmoudi R. SCREENING FOR FRAILTY IN COMMUNITY-DWELLING ELDERLY SUBJECTS: VALIDATION OF THE SEGAM INSTRUMENT. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- N. Oubaya
- Reims Teaching Hospitals, Reims, France,
| | - M. Drame
- Reims Teaching Hospitals, Reims, France,
| | - J. Novella
- Reims Teaching Hospitals, Reims, France,
| | | | - C. Cunin
- Caisse d’Assurance retraite et de Santé au travail du Nord-Est, Mission RELAIS – Actions collectives gérontologiques, Nancy, France
| | - D. Jolly
- Reims Teaching Hospitals, Reims, France,
| | | |
Collapse
|
31
|
Polivka L, Oubaya N, Richard MA, Chosidow O, Bachelez H, Canoui-Poitrine F, Sbidian E. Évolution du profil et du nombre de cas de psoriasis hospitalisés : une analyse en série chronologique de 700 patients entre 2003 et 2013. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
32
|
Hocine A, Belmokhtar K, Bauley K, Jaisson S, Gaha K, Oubaya N, Lesaffre F, Lavaud S, Halin P, Gillery P, Rieu P, Touré F. Serum and Tissue Accumulation of Advanced Glycation End-Products Correlates with Vascular Changes. Perit Dial Int 2016; 35:592-4. [PMID: 26450482 DOI: 10.3747/pdi.2013.00338] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
| | | | | | | | | | - Nadia Oubaya
- Clinical Investigation Center, CHU Reims, France
| | | | | | - Pascale Halin
- Division of Nephrology, Manchester Hospital, Charleville Méziéres, France
| | | | - Philippe Rieu
- Division of Nephrology, CHU Reims, France Laboratory of Nephrology, UMR CNRS URCA 7369, CHU Reims, France
| | - Fatouma Touré
- Division of Nephrology, CHU Reims, France Laboratory of Nephrology, UMR CNRS URCA 7369, CHU Reims, France
| |
Collapse
|
33
|
Kanagaratnam L, Dramé M, Trenque T, Oubaya N, Nazeyrollas P, Novella JL, Jolly D, Mahmoudi R. Adverse drug reactions in elderly patients with cognitive disorders: A systematic review. Maturitas 2016; 85:56-63. [DOI: 10.1016/j.maturitas.2015.12.013] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2015] [Revised: 12/21/2015] [Accepted: 12/22/2015] [Indexed: 11/28/2022]
|
34
|
Oubaya N, Mahmoudi R, Kanagaratnam L, Jolly D, Novella J, Dramé M. P118: Screening for frailty in elderly subjects living at home: validation of the modified Short Emergency Geriatric Assessment (SEGAm) instrument. Eur Geriatr Med 2014. [DOI: 10.1016/s1878-7649(14)70292-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
35
|
Oubaya N, Mahmoudi R, Jolly D, Zulfiqar AA, Quignard E, Cunin C, Nazeyrollas P, Novella JL, Dramé M. Screening for frailty in elderly subjects living at home: validation of the Modified Short Emergency Geriatric Assessment (SEGAm) instrument. J Nutr Health Aging 2014; 18:757-64. [PMID: 25286456 DOI: 10.1007/s12603-014-0541-1] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVES To validate the modified version of the Short Emergency Geriatric Assessment (SEGAm) frailty instrument in elderly people living at home. DESIGN Longitudinal, prospective, multicentre study. SETTING Four departments (Ardennes, Marne, Meurthe-et-Moselle, Meuse) in two French Regions (Champagne-Ardenne and Lorraine). PARTICIPANTS Subjects aged 65 years or more, living at home, who could read and understand French, with a degree of autonomy corresponding to groups 5, or 6 in the AGGIR autonomy evaluation scale. MEASUREMENTS Assessment included demographic characteristics, comprehensive geriatric assessment, and the SEGAm instrument. Psychometric validation was used to study feasibility and acceptability, internal structure validity, reliability, and discriminant validity of the SEGAm instrument. RESULTS Between July 1st 2012 and March 31st 2013, 167 patients were included in the study. Averaged age was 77±7 years, the majority were women (70.7%). Feasibility and acceptability of the SEGAm instrument were excellent: we observed no refusal to participate, no drop-out during administration, no missing items, no ceiling or floor effects, and the administration time was short (5.0±3.5 min). By factor analysis, the instrument proved to be unidimensional. It showed good internal consistency (Cronbach's alpha coefficient: 0.68) and good test-retest (intra-class correlation: 0.88) at 7 days interval. Discriminant validity showed a significant difference, mainly for nutritional status, fall risk, dependency, mood and depression risk, and comorbidities. CONCLUSION Based on these psychometric properties, the SEGAm appears to be an easy-to-use instrument that is particularly suitable for use in the community to identify frail elderly people who could benefit from early targeted interventions.
Collapse
Affiliation(s)
- N Oubaya
- Moustapha Dramé MD, MPH, PhD, Department of Research and Innovation, Reims Teaching Hospitals, Robert Debré Hospital, Avenue du Général Koenig - 51092 Reims cedex, France, Telephone: + 33 3 26 78 44 12, Fax: + 33 3 26 83 25 89, E-mail:
| | | | | | | | | | | | | | | | | |
Collapse
|